Aberrant DNA Methylation of Calcitonin Receptor in Fabry Patients Treated with Enzyme Replacement Therapy

Overview

Journal Mol Genet Metab Rep

Specialty Endocrinology

Date 2017 Jun 27

PMID 28649534

Citations 5

Authors

Anna Hubner

Thomas Metz

Andrea Schanzer

Susanne Greber-Platzer

Chike Bellarmine Item

Affiliations

Soon will be listed here.

Citing Articles

The landscape of CRISPR/Cas9 for inborn errors of metabolism.

Leal A, Fnu N, Benincore-Florez E, Herreno-Pachon A, Echeverri-Pena O, Almeciga-Diaz C Mol Genet Metab. 2022; 138(1):106968.

PMID: 36525790 PMC: 10199355. DOI: 10.1016/j.ymgme.2022.106968.

Pathogenesis and Molecular Mechanisms of Anderson-Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies.

Tuttolomondo A, Simonetta I, Riolo R, Todaro F, Di Chiara T, Miceli S Int J Mol Sci. 2021; 22(18).

PMID: 34576250 PMC: 8465525. DOI: 10.3390/ijms221810088.

DNA methylation impact on Fabry disease.

Di Risi T, Vinciguerra R, Cuomo M, Della Monica R, Riccio E, Cocozza S Clin Epigenetics. 2021; 13(1):24.

PMID: 33531072 PMC: 7852133. DOI: 10.1186/s13148-021-01019-3.

Biomarkers of Fabry Nephropathy: Review and Future Perspective.

Levstek T, Vujkovac B, Trebusak Podkrajsek K Genes (Basel). 2020; 11(9).

PMID: 32962051 PMC: 7564978. DOI: 10.3390/genes11091091.

Altered Gene Expression in Prefrontal Cortex of a Fabry Disease Mouse Model.

Kummer K, Kalpachidou T, Mitric M, Langeslag M, Kress M Front Mol Neurosci. 2018; 11:201.

PMID: 30013462 PMC: 6036252. DOI: 10.3389/fnmol.2018.00201.

References

Kanngiesser M, Mair N, Lim H, Zschiebsch K, Blees J, Haussler A . Hypoxia-inducible factor 1 regulates heat and cold pain sensitivity and persistence. Antioxid Redox Signal. 2013; 20(16):2555-71. DOI: 10.1089/ars.2013.5494. View

Yu L, Hou J, Fu F, Zhang Y . Roles of calcitonin gene-related peptide and its receptors in pain-related behavioral responses in the central nervous system. Neurosci Biobehav Rev. 2009; 33(8):1185-91. DOI: 10.1016/j.neubiorev.2009.03.009. View

Cramer T, Johnson R . A novel role for the hypoxia inducible transcription factor HIF-1alpha: critical regulation of inflammatory cell function. Cell Cycle. 2003; 2(3):192-3. View

Hsieh Y, Chou L, Chang P, Yang C, Kao M, Hong C . Low-level laser therapy alleviates neuropathic pain and promotes function recovery in rats with chronic constriction injury: possible involvements in hypoxia-inducible factor 1α (HIF-1α). J Comp Neurol. 2012; 520(13):2903-16. DOI: 10.1002/cne.23072. View

Lidove O, Bekri S, Goizet C, Van Kien A, Aractingi S, Knebelmann B . [Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up]. Presse Med. 2007; 36(7-8):1084-97. DOI: 10.1016/j.lpm.2007.01.006. View

Zarate Y, Hopkin R . Fabry's disease. Lancet. 2008; 372(9647):1427-35. DOI: 10.1016/S0140-6736(08)61589-5. View

Wenger R, Kvietikova I, Rolfs A, Camenisch G, Gassmann M . Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur J Biochem. 1998; 253(3):771-7. DOI: 10.1046/j.1432-1327.1998.2530771.x. View

Schiffmann R, Floeter M, Dambrosia J, Gupta S, Moore D, Sharabi Y . Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve. 2003; 28(6):703-10. DOI: 10.1002/mus.10497. View

Tuttolomondo A, Pecoraro R, Simonetta I, Miceli S, Arnao V, Licata G . Neurological complications of Anderson-Fabry disease. Curr Pharm Des. 2013; 19(33):6014-30. DOI: 10.2174/13816128113199990387. View

10.

Zaidi M, Breimer L, MacIntyre I . Biology of peptides from the calcitonin genes. Q J Exp Physiol. 1987; 72(4):371-408. DOI: 10.1113/expphysiol.1987.sp003084. View

11.

Ueda H, Uchida H . Epigenetic modification in neuropathic pain. Curr Pharm Des. 2014; 21(7):849-67. DOI: 10.2174/1381612820666141027113923. View

12.

Rossler J, Stolze I, Frede S, Freitag P, Schweigerer L, Havers W . Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site. J Cell Biochem. 2004; 93(1):153-61. DOI: 10.1002/jcb.20133. View

13.

Schiffmann R . Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy. Acta Neurol Belg. 2006; 106(2):61-5. View

14.

Oka N, Kawasaki T, Mizutani K, Sugiyama H, Akiguchi I . Hypoxia-inducible factor 1alpha may be a marker for vasculitic neuropathy. Neuropathology. 2007; 27(6):509-15. DOI: 10.1111/j.1440-1789.2007.00817.x. View

15.

Moller A, Jensen T . Neurological manifestations in Fabry's disease. Nat Clin Pract Neurol. 2007; 3(2):95-106. DOI: 10.1038/ncpneuro0407. View

16.

Tendl K, Schulz S, Mechtler T, Bohn A, Metz T, Greber-Platzer S . DNA methylation pattern of CALCA in preterm neonates with bacterial sepsis as a putative epigenetic biomarker. Epigenetics. 2013; 8(12):1261-7. PMC: 3933487. DOI: 10.4161/epi.26645. View